Clinical Trials
25
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (24 trials with phase data)• Click on a phase to view related trials
Long-term Safety Study of Chronocort in the Treatment of Participants with Congenital Adrenal Hyperplasia
- First Posted Date
- 2022-03-29
- Last Posted Date
- 2024-11-12
- Lead Sponsor
- Diurnal Limited
- Target Recruit Count
- 76
- Registration Number
- NCT05299554
- Locations
- 🇺🇸
Diurnal Investigational Site in California, Orange, California, United States
🇺🇸Diurnal Investigational Site in Florida, Jacksonville, Florida, United States
🇺🇸Diurnal Investigational Site in Iowa, Iowa City, Iowa, United States
Chronocort Versus Plenadren Replacement Therapy in Adults With Adrenal Insufficiency
- First Posted Date
- 2022-02-03
- Last Posted Date
- 2024-05-14
- Lead Sponsor
- Diurnal Limited
- Target Recruit Count
- 58
- Registration Number
- NCT05222152
- Locations
- 🇩🇪
Diurnal Investigational Site in Hamburg, Hamburg, Germany
🇩🇪Diurnal Investigational Site in Munich, Munich, Germany
🇩🇪Diurnal Investigational Site in Würzburg, Würzburg, Germany
Comparison of Chronocort Versus Standard Hydrocortisone Replacement Therapy in Participants Aged 16 Years and Over With Congenital Adrenal Hyperplasia
- Conditions
- Congenital Adrenal Hyperplasia
- Interventions
- First Posted Date
- 2021-10-01
- Last Posted Date
- 2025-02-25
- Lead Sponsor
- Neurocrine UK Limited
- Target Recruit Count
- 55
- Registration Number
- NCT05063994
- Locations
- 🇺🇸
Diurnal Investigational Site in Los Angeles, Los Angeles, California, United States
🇺🇸Diurnal Investigational Site in Orange, Orange, California, United States
🇺🇸Diurnal Investigational Site in Jacksonville, Jacksonville, Florida, United States
Open-label Comparison of Chronocort® Versus Standard Glucocorticoid Replacement Therapy
- Conditions
- Congenital Adrenal Hyperplasia
- Interventions
- Drug: Chronocort®Drug: Standard Care
- First Posted Date
- 2018-05-22
- Last Posted Date
- 2022-04-08
- Lead Sponsor
- Diurnal Limited
- Registration Number
- NCT03532022
- Locations
- 🇺🇸
Diabetes and Endocrinology Consultants PC, Morehead City, North Carolina, United States
A Study of Chronocort® Versus Cortef ® in Healthy Adult Male Subjects
- First Posted Date
- 2017-11-17
- Last Posted Date
- 2020-06-19
- Lead Sponsor
- Diurnal Limited
- Target Recruit Count
- 25
- Registration Number
- NCT03343327
- Locations
- 🇬🇧
Simbec Research Ltd., Merthyr Tydfil, United Kingdom
- Prev
- 1
- 2
- 3
- 4
- Next